National Hospital Organization Kyushu Medical Center; Respiratory Internal Medicine
Fukuoka 810-8563
0 studies enrolling now · 2 studies all time
What they study most
Non-Small Cell Lung Cancer, Squamous Non-Small Cell Lung Cancer
Studies at this site
- A Study of Atezolizumab in Combination With Carboplatin + Paclitaxel or Carboplatin + Nab-Paclitaxel Compared With Carboplatin + Nab-Paclitaxel in Participants With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC) [IMpower131] — Completed
- A Study of Atezolizumab in Participants With Programmed Death - Ligand 1 (PD-L1) Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer — Completed